2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Ixazomib Citrate: new trials by email Literature Review of Ixazomib Citrate trials Research Report on Ixazomib Citrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Multiple Myeloma | Phase 3 | Completed | National Cancer Institute (NCI) | 1 | 2022-02-16 | 2025-05-23 |
| A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant Ixazomib Citrate, Placebo - Multiple Myeloma, Autologous Stem Cell Transplant | Phase 3 | Completed | Takeda | 656 | 2014-07-16 | 2024-11-19 |
Multiple Myeloma (2)
National Cancer Institute (NCI) (1) · Takeda (1)
United States (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Colombia (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1)
Shaji K Kumar (1)
PMID 30545780, PMID 31880006, PMID 32613281, PMID 36130300
U10CA180820 (1)